申请人:MEDIVIR AB
公开号:WO2010042030A1
公开(公告)日:2010-04-15
A compound of formula (I): N-oxides, addition salts, quaternary amines metal complexes stereochemically isomeric forms and metabolites thereof, wherein A is CR1 or N; D is H, C1-C6alkyl, C2-C6alkenyl, C2-C6alkynyl or Q is C2-C6alkenyl, C2-Cealkynyl, aryl or heterocyclyl; W is H, Ci-Cealkyl, C2-C6alkenyl, haloC1-C3alkyl, hydroxyC1-C3alkyl, C3-C6Cy cloalkyl, aryl or heterocyclyl; one of X' and X" is H or CH3, the other is C1-C3alkyl, F, OH, NRaRb, CF3 or N3; or X' and X" are both F; Y is a bond, CH2, NRa, O, CH2CH2, CH2NRa, CH2O or S(=O)r; Z is O, S(=O)r or NRa; the other variables are as defined in the specification. The compounds of the invention are inhibitors of BACE and are among other things useful for the treatment and/or prevention of conditions associated with BACE activity such as Alzheimer's disease.
公式(I)的化合物为:N-氧化物、加合盐、季铵盐金属配合物立体化学异构体及其代谢物,其中A为CR1或N;D为H、C1-C6烷基、C2-C6烯基、C2-C6炔基或Q为C2-C6烯基、C2-C6炔基、芳基或杂环基;W为H、C1-C6烷基、C2-C6烯基、卤代C1-C3烷基、羟基C1-C3烷基、C3-C6环烷基、芳基或杂环基;X'和X"中的一个为H或CH3,另一个为C1-C3烷基、F、OH、NRaRb、CF3或N3;或X'和X"都是F;Y为键、CH2、NRa、O、CH2CH2、CH2NRa、CH2O或S(=O)r;Z为O、S(=O)r或NRa;其他变量如规范中所定义。该发明的化合物是BACE的抑制剂,可用于治疗和/或预防与BACE活性相关的疾病,如阿尔茨海默病。